| Year |
Citation |
Score |
| 2016 |
Gabunia K, Ellison S, Kelemen S, Kako F, Cornwell WP, Rogers TJ, Data PK, Ouimet M, Moore KJ, Autieri MV. IL-19 Halts Progression of Atherosclerotic Plaque, Polarizes, and Increases Cholesterol Uptake and Efflux in Macrophages. The American Journal of Pathology. PMID 26952642 DOI: 10.1016/J.Ajpath.2015.12.023 |
0.759 |
|
| 2014 |
Ellison S, Gabunia K, Richards JM, Kelemen SE, England RN, Rudic D, Azuma YT, Munroy MA, Eguchi S, Autieri MV. IL-19 reduces ligation-mediated neointimal hyperplasia by reducing vascular smooth muscle cell activation. The American Journal of Pathology. 184: 2134-43. PMID 24814101 DOI: 10.1016/J.Ajpath.2014.04.001 |
0.66 |
|
| 2013 |
Ellison S, Gabunia K, Kelemen SE, England RN, Scalia R, Richards JM, Orr AW, Orr W, Traylor JG, Rogers T, Cornwell W, Berglund LM, Goncalves I, Gomez MF, Autieri MV. Attenuation of experimental atherosclerosis by interleukin-19. Arteriosclerosis, Thrombosis, and Vascular Biology. 33: 2316-24. PMID 23950143 DOI: 10.1161/Atvbaha.113.301521 |
0.651 |
|
| 2012 |
Gabunia K, Ellison SP, Singh H, Datta P, Kelemen SE, Rizzo V, Autieri MV. Interleukin-19 (IL-19) induces heme oxygenase-1 (HO-1) expression and decreases reactive oxygen species in human vascular smooth muscle cells. The Journal of Biological Chemistry. 287: 2477-84. PMID 22158875 DOI: 10.1074/Jbc.M111.312470 |
0.762 |
|
| 2012 |
Sommerville LJ, Kelemen SE, Ellison SP, England RN, Autieri MV. Increased atherosclerosis and vascular smooth muscle cell activation in AIF-1 transgenic mice fed a high-fat diet. Atherosclerosis. 220: 45-52. PMID 21862018 DOI: 10.1016/J.Atherosclerosis.2011.07.095 |
0.62 |
|
| Show low-probability matches. |